Sildenafil: Difference between revisions

From Citizendium
Jump to navigation Jump to search
imported>David E. Volk
(chemistry and drug interactions)
imported>David E. Volk
(mechanism)
Line 15: Line 15:
}}
}}
'''Sildenafil''', widely known as [[Viagra]]®, is a medication used to treat [[erectile dysfunction]].  It is also marketed as Ravatio® as an oral treatment for pulmonary arterial hypertension. Both drugs are sold as the citrate salt of sildenafil.  It was the first commercialized ''selective'' [[phosphodiesterase]] type 5 ([[PDE-5]]) inhibitor and was immediately popular both for treating erectile dysfunction and for recreational use.  Sildenafil works by binding to phosphodiesterase type-5 enzymes, competing with the natural ligand [[cyclic guanine monophosphate]] (cGMP), which is structurally similar to sildenafil.  [[Vardenafil]], a newer and more potent PDE-5 inhibitor, is nearly identical to sildenafil, while [[tadalafil]] is considerably different in structure.
'''Sildenafil''', widely known as [[Viagra]]®, is a medication used to treat [[erectile dysfunction]].  It is also marketed as Ravatio® as an oral treatment for pulmonary arterial hypertension. Both drugs are sold as the citrate salt of sildenafil.  It was the first commercialized ''selective'' [[phosphodiesterase]] type 5 ([[PDE-5]]) inhibitor and was immediately popular both for treating erectile dysfunction and for recreational use.  Sildenafil works by binding to phosphodiesterase type-5 enzymes, competing with the natural ligand [[cyclic guanine monophosphate]] (cGMP), which is structurally similar to sildenafil.  [[Vardenafil]], a newer and more potent PDE-5 inhibitor, is nearly identical to sildenafil, while [[tadalafil]] is considerably different in structure.
== Mechanism of action ==
By competitively binding to PDE-5 enzymes in smooth muscle and therefore inhibiting the binding of cGMP to PDE-5, the degradation of cGMP is reduced resulting in elevated levels of cGMP in the [[corpus cavernosum]] and its supply vessels.  The elevated cGMP levels relax the smooth muscles, dilate the [[corporeal sinusoid]]s and increase blood flow enabling an erection.


== Chemistry ==
== Chemistry ==

Revision as of 16:48, 21 June 2008

This article is developing and not approved.
Main Article
Discussion
Related Articles  [?]
Bibliography  [?]
External Links  [?]
Citable Version  [?]
 
This editable Main Article is under development and subject to a disclaimer.
Sildenafil3.jpg
sildenafil
IUPAC name: see Chemistry
Synonyms: Viagra®
Formula:

 Uses: Erectile Dysfunction

 Properties: PDE-5 inhibitor

 Hazards: cardiovascular risks

Mass (g/mol): CAS #:
666.7 (citrate)


Sildenafil, widely known as Viagra®, is a medication used to treat erectile dysfunction. It is also marketed as Ravatio® as an oral treatment for pulmonary arterial hypertension. Both drugs are sold as the citrate salt of sildenafil. It was the first commercialized selective phosphodiesterase type 5 (PDE-5) inhibitor and was immediately popular both for treating erectile dysfunction and for recreational use. Sildenafil works by binding to phosphodiesterase type-5 enzymes, competing with the natural ligand cyclic guanine monophosphate (cGMP), which is structurally similar to sildenafil. Vardenafil, a newer and more potent PDE-5 inhibitor, is nearly identical to sildenafil, while tadalafil is considerably different in structure.

Mechanism of action

By competitively binding to PDE-5 enzymes in smooth muscle and therefore inhibiting the binding of cGMP to PDE-5, the degradation of cGMP is reduced resulting in elevated levels of cGMP in the corpus cavernosum and its supply vessels. The elevated cGMP levels relax the smooth muscles, dilate the corporeal sinusoids and increase blood flow enabling an erection.

Chemistry

The IUPAC name of sildenafil is 1-[[3-(6,7-dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo [4,3-d] pyrimidin-5-yl)-4-ethoxyphenyl] sulfonyl]-4-methylpiperazine and it has a molecular mass of 666.7 g/mol (as the citrate salt).

Drug interactions

Because sildenafil has vasodilator properties that result in decreased blood pressure, the combined use of sildenafil with other vasodilators, such as alpha-blockers, must be done cautiously. Patients with a history of heart attacks, strokes, arrythmia, hypertension, retinitis pigmentosa or currently on bosentan therapy.

Up-to-Date Information

The most up-to-date information about this and other drugs can be found at the following sites.

References

J. D. Corbin and S. H. Sharron. "Molecular Biology and Pharmacology of PDE-5-Inhibitor Therapy for Erectile Dysfunction". J. Androl. 24: S38-S41.